1
|
Faust O, De Michele S, Koh JE, Jahmunah V, Lih OS, Kamath AP, Barua PD, Ciaccio EJ, Lewis SK, Green PH, Bhagat G, Acharya UR. Automated analysis of small intestinal lamina propria to distinguish normal, Celiac Disease, and Non-Celiac Duodenitis biopsy images. Comput Methods Programs Biomed 2023; 230:107320. [PMID: 36608429 DOI: 10.1016/j.cmpb.2022.107320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2022] [Revised: 12/16/2022] [Accepted: 12/18/2022] [Indexed: 06/17/2023]
Abstract
BACKGROUND AND OBJECTIVE Celiac Disease (CD) is characterized by gluten intolerance in genetically predisposed individuals. High disease prevalence, absence of a cure, and low diagnosis rates make this disease a public health problem. The diagnosis of CD predominantly relies on recognizing characteristic mucosal alterations of the small intestine, such as villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. However, these changes are not entirely specific to CD and overlap with Non-Celiac Duodenitis (NCD) due to various etiologies. We investigated whether Artificial Intelligence (AI) models could assist in distinguishing normal, CD, and NCD (and unaffected individuals) based on the characteristics of small intestinal lamina propria (LP). METHODS Our method was developed using a dataset comprising high magnification biopsy images of the duodenal LP compartment of CD patients with different clinical stages of CD, those with NCD, and individuals lacking an intestinal inflammatory disorder (controls). A pre-processing step was used to standardize and enhance the acquired images. RESULTS For the normal controls versus CD use case, a Support Vector Machine (SVM) achieved an Accuracy (ACC) of 98.53%. For a second use case, we investigated the ability of the classification algorithm to differentiate between normal controls and NCD. In this use case, the SVM algorithm with linear kernel outperformed all the tested classifiers by achieving 98.55% ACC. CONCLUSIONS To the best of our knowledge, this is the first study that documents automated differentiation between normal, NCD, and CD biopsy images. These findings are a stepping stone toward automated biopsy image analysis that can significantly benefit patients and healthcare providers.
Collapse
Affiliation(s)
| | - Simona De Michele
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, USA
| | - Joel Ew Koh
- Department of Computer Engineering, Ngee Ann Polytechnic, Singapore, Singapore
| | - V Jahmunah
- Department of Computer Engineering, Ngee Ann Polytechnic, Singapore, Singapore
| | - Oh Shu Lih
- Department of Computer Engineering, Ngee Ann Polytechnic, Singapore, Singapore
| | | | - Prabal Datta Barua
- Cogninet Australia, Sydney, NSW 2010, Australia; School of Management & Enterprise, University of Southern Queensland, Australia; Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW 2007, Australia
| | - Edward J Ciaccio
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - Suzanne K Lewis
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - Peter H Green
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - Govind Bhagat
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, USA; Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - U Rajendra Acharya
- School of Science and Technology, Singapore University of Social Sciences, 463 Clementi Road, 599494, Singapore; Department of Computer Engineering, Ngee Ann Polytechnic, Singapore, Singapore; Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan.
| |
Collapse
|
2
|
Mishra N, Ng J, Strom MA, Jain K, Thakkar R, Joshi S, Pereira M, Shah L, Grossman ME, Lee MJ, De Michele S, Silvers DN, Faust PL, Lipkin WI, Gallitano SM. Human Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant Recipients. JAMA Dermatol 2022; 158:293-298. [PMID: 35138364 PMCID: PMC8829745 DOI: 10.1001/jamadermatol.2021.5853] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
IMPORTANCE We describe the first report to our knowledge of cutaneous and systemic pathogenicity of human polyomavirus 9 in solid organ transplant recipients. OBJECTIVE Three solid organ transplant recipients developed a widespread, progressive, violaceous, and hyperkeratotic skin eruption. All died from pulmonary and multiorgan failure around 1 year from onset of the rash. Routine clinical diagnostic testing could not identify any causative agent; therefore, samples and autopsies were investigated for novel pathogens using high-throughput sequencing. DESIGN, SETTING, AND PARTICIPANTS This case series, including 3 solid organ transplant recipients who developed characteristic pink, violaceous, or brown hyperkeratotic papules and plaques throughout the body, was conducted at the Columbia University Medical Center. Lesional skin biopsies were collected from all 3 patients and subjected to high-throughput illumina sequencing for identification of microbial pathogens. Human polyomavirus 9 was identified in lesional skin biopsies. We subsequently collected ocular swabs, oral swabs, urine samples, and blood samples from patients, and organ tissues at autopsy in 1 patient. We investigated these samples for the presence of human polyomavirus 9 using in situ hybridization and quantitative polymerase chain reaction (PCR) assays. MAIN OUTCOMES AND MEASURES A description of the clinical and pathologic findings of 3 patients. RESULTS This case series study found that human polyomavirus 9 was detected in the skin biopsies of all 3 patients by a capture-based high-throughput sequencing method platform (VirCapSeq-VERT). Human polyomavirus 9 was also detected in blood, oral, ocular swabs, and urine by real-time polymerase chain reaction (PCR) assay. In situ hybridization and quantitative PCR assays were performed on the skin biopsies from 3 patients and lung autopsy of 1 patient, which showed the presence of human polyomavirus 9 messenger RNA transcripts, indicating active viral replication and pathogenesis in the skin and lungs. CONCLUSIONS AND RELEVANCE Human polyomavirus 9 was associated with the widespread cutaneous eruption. All 3 patients had progression of cutaneous disease, accompanied by clinical deterioration, pulmonary failure, and death. One patient underwent autopsy and human polyomavirus 9 was identified in the lungs and paratracheal soft tissue. These findings suggest that human polyomavirus 9 may be associated with cutaneous and possibly pulmonary infection and death in solid organ transplant recipients.
Collapse
Affiliation(s)
- Nischay Mishra
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York
| | - James Ng
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York
| | - Mark A. Strom
- Department of Dermatology, Mount Sinai Hospital, New York, New York
| | - Komal Jain
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York
| | - Riddhi Thakkar
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York
| | - Shreyas Joshi
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York
| | - Marcus Pereira
- Department of Medicine, Columbia University Irving Medical Center, New York, New York
| | - Lori Shah
- Department of Medicine, Columbia University Irving Medical Center, New York, New York
| | - Marc E. Grossman
- Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut,Hofstra/Northwell Donald and Barbara Zucker School of Medicine, New Hyde Park, New York
| | - Michael J. Lee
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York
| | - Simona De Michele
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York
| | - David N. Silvers
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York,Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| | - Phyllis L. Faust
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York
| | - W. Ian Lipkin
- Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York
| | - Stephanie M. Gallitano
- Department of Dermatology, Columbia University Irving Medical Center, New York, New York
| |
Collapse
|
3
|
Koh JEW, De Michele S, Sudarshan VK, Jahmunah V, Ciaccio EJ, Ooi CP, Gururajan R, Gururajan R, Oh SL, Lewis SK, Green PH, Bhagat G, Acharya UR. Automated interpretation of biopsy images for the detection of celiac disease using a machine learning approach. Comput Methods Programs Biomed 2021; 203:106010. [PMID: 33831693 DOI: 10.1016/j.cmpb.2021.106010] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Accepted: 02/15/2021] [Indexed: 06/12/2023]
Abstract
BACKGROUND AND OBJECTIVES Celiac disease is an autoimmune disease occurring in about 1 in 100 people worldwide. Early diagnosis and efficient treatment are crucial in mitigating the complications that are associated with untreated celiac disease, such as intestinal lymphoma and malignancy, and the subsequent high morbidity. The current diagnostic methods using small intestinal biopsy histopathology, endoscopy, and video capsule endoscopy (VCE) involve manual interpretation of photomicrographs or images, which can be time-consuming and difficult, with inter-observer variability. In this paper, a machine learning technique was developed for the automation of biopsy image analysis to detect and classify villous atrophy based on modified Marsh scores. This is one of the first studies to employ conventional machine learning to automate the use of biopsy images for celiac disease detection and classification. METHODS The Steerable Pyramid Transform (SPT) method was used to obtain sub bands from which various types of entropy and nonlinear features were computed. All extracted features were automatically classified into two-class and multi-class, using six classifiers. RESULTS An accuracy of 88.89%, was achieved for the classification of two-class villous abnormalities based on analysis of Hematoxylin and Eosin (H&E) stained biopsy images. Similarly, an accuracy of 82.92% was achieved for the two-class classification of red-green-blue (RGB) biopsy images. Also, an accuracy of 72% was achieved in the classification of multi-class biopsy images. CONCLUSION The results obtained are promising, and demonstrate the possibility of automating biopsy image interpretation using machine learning. This can assist pathologists in accelerating the diagnostic process without bias, resulting in greater accuracy, and ultimately, earlier access to treatment.
Collapse
Affiliation(s)
- Joel En Wei Koh
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Singapore
| | - Simona De Michele
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, USA
| | - Vidya K Sudarshan
- School of Science and Technology, Singapore University of Social Sciences, Singapore
| | - V Jahmunah
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Singapore
| | - Edward J Ciaccio
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - Chui Ping Ooi
- School of Science and Technology, Singapore University of Social Sciences, Singapore
| | - Raj Gururajan
- School of Business, University of Southern Queensland Springfield, Australia
| | | | - Shu Lih Oh
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Singapore
| | - Suzanne K Lewis
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - Peter H Green
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA
| | - Govind Bhagat
- Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, USA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, USA
| | - U Rajendra Acharya
- Department of Electronics and Computer Engineering, Ngee Ann Polytechnic, Singapore; School of Science and Technology, Singapore University of Social Sciences, Singapore; School of Business, University of Southern Queensland Springfield, Australia; Department of Bioinformatics and Medical Engineering, Asia University, Taiwan; International Research Organization for Advanced Science and Technology (IROAST) Kumamoto University, Kumamoto, Japan.
| |
Collapse
|
4
|
De Michele S, Remotti HE, Del Portillo A, Lagana SM, Szabolcs M, Saqi A. SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins. Am J Clin Pathol 2021; 155:124-132. [PMID: 32914850 DOI: 10.1093/ajcp/aqaa118] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
OBJECTIVES Special AT-rich binding protein 2 (SATB2) immunohistochemistry (IHC) has high sensitivity and specificity for colorectal adenocarcinoma (CRC), but data on its expression in specific subsets of pulmonary, gastric, small bowel, and pancreatobiliary adenocarcinomas (ADCAs) are relatively limited or discordant. We assessed SATB2 expression in a large cohort of ADCAs from these sites to determine its reliability in distinguishing CRC from them. METHODS SATB2 IHC was performed on 335 neoplasms, including 40 lung ADCAs, 165 pancreatobiliary neoplasms (34 intraductal papillary mucinous neoplasms [IPMNs], 19 pancreatic ADCAs, 112 cholangiocarcinomas [CCs]), and 35 gastric, 13 small bowel, 36 ampullary (AMP), and 46 CRC ADCAs. The cases were evaluated for positivity (defined as ≥5% nuclear staining), and an H-score was calculated based on the percentage of SATB2+ cells and staining intensity. Analysis was performed to determine the optimal H-score threshold to separate CRC and non-CRC. RESULTS SATB2 was positive in 3% of lung, 2% of CC, 17% of gastric, 38% of small bowel, and 6% of AMP ADCAs. All pancreatic ADCA/IPMNs were negative, and 87% CRCs were positive. CONCLUSIONS SATB2 is not entirely specific for colorectal origin and can be expressed in a subset of gastrointestinal ADCAs. It is most useful in the differential of CRC vs lung and pancreatobiliary ADCAs.
Collapse
Affiliation(s)
- Simona De Michele
- Department of Pathology and Cell Biology at Columbia University Irving Medical Center, New York, NY
| | - Helen E Remotti
- Department of Pathology and Cell Biology at Columbia University Irving Medical Center, New York, NY
| | - Armando Del Portillo
- Department of Pathology and Cell Biology at Columbia University Irving Medical Center, New York, NY
| | - Stephen M Lagana
- Department of Pathology and Cell Biology at Columbia University Irving Medical Center, New York, NY
| | - Matthias Szabolcs
- Department of Pathology and Cell Biology at Columbia University Irving Medical Center, New York, NY
| | - Anjali Saqi
- Department of Pathology and Cell Biology at Columbia University Irving Medical Center, New York, NY
| |
Collapse
|
5
|
De Michele S, Sun Y, Yilmaz MM, Katsyv I, Salvatore M, Dzierba AL, Marboe CC, Brodie D, Patel NM, Garcia CK, Saqi A. Forty Postmortem Examinations in COVID-19 Patients. Am J Clin Pathol 2020; 154:748-760. [PMID: 32876680 PMCID: PMC7499554 DOI: 10.1093/ajcp/aqaa156] [Citation(s) in RCA: 69] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVES Although diffuse alveolar damage, a subtype of acute lung injury (ALI), is the most common microscopic pattern in coronavirus disease 2019 (COVID-19), other pathologic patterns have been described. The aim of the study was to review autopsies from COVID-19 decedents to evaluate the spectrum of pathology and correlate the results with clinical, laboratory, and radiologic findings. METHODS A comprehensive and quantitative review from 40 postmortem examinations was performed. The microscopic patterns were categorized as follows: "major" when present in more than 50% of cases and "novel" if rarely or not previously described and unexpected clinically. RESULTS Three major pulmonary patterns were identified: ALI in 29 (73%) of 40, intravascular fibrin or platelet-rich aggregates (IFPAs) in 36 (90%) of 40, and vascular congestion and hemangiomatosis-like change (VCHL) in 20 (50%) of 40. The absence of ALI (non-ALI) was novel and seen in 11 (27%) of 40. Compared with ALI decedents, those with non-ALI had a shorter hospitalization course (P = .02), chest radiographs with no or minimal consolidation (P = .01), and no pathologically confirmed cause of death (9/11). All non-ALI had VCHL and IFPAs, and clinically most had cardiac arrest. CONCLUSIONS Two distinct pulmonary phenotypic patterns-ALI and non-ALI-were noted. Non-ALI represents a rarely described phenotype. The cause of death in non-ALI is most likely COVID-19 related but requires additional corroboration.
Collapse
Affiliation(s)
| | - Yu Sun
- Department of Pathology and Cell Biology
| | | | | | | | | | | | - Daniel Brodie
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center and the NewYork-Presbyterian Hospital, New York, NY
| | - Nina M Patel
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center and the NewYork-Presbyterian Hospital, New York, NY
| | - Christine K Garcia
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center and the NewYork-Presbyterian Hospital, New York, NY
| | | |
Collapse
|
6
|
Lagana SM, De Michele S, Lee MJ, Emond JC, Griesemer AD, Tulin-Silver SA, Verna EC, Martinez M, Lefkowitch JH. COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation. Arch Pathol Lab Med 2020; 144:929-932. [PMID: 32302212 DOI: 10.5858/arpa.2020-0186-sa] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
We present a case of COVID-19 hepatitis in a living donor liver allograft recipient whose donor subsequently tested positive for COVID-19. The patient is a female infant with biliary atresia (failed Kasai procedure). She recovered well, with improving liver function tests for 4 days. On post-operative day (POD) 4 the patient developed respiratory distress and fever. COVID-19 testing (polymerase chain reaction) was positive. Liver function tests increased approximately 5-fold. Liver biopsy showed moderate acute hepatitis with prominent clusters of apoptotic hepatocytes and associated cellular debris. Lobular lymphohistiocytic inflammation was noted. Typical portal features of mild to moderate acute cellular rejection were also noted.
Collapse
Affiliation(s)
- Stephen M Lagana
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Simona De Michele
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Michael J Lee
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Jean C Emond
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Adam D Griesemer
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Sheryl A Tulin-Silver
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Elizabeth C Verna
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Mercedes Martinez
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| | - Jay H Lefkowitch
- Department of Pathology and Cell Biology (Dr. Lagana, Dr. De Michele, Dr. Lee, Dr. Lefkowitch); Department of Surgery (Dr. Emond, Dr. Griesemer); Department of Radiology (Dr Tulin-Silver); Department of Medicine Digestive and Liver Disease (Dr. Verna); Department of Pediatrics (Dr. Martinez), at the Columbia University Medical Center
| |
Collapse
|